Markets:

Overview

News

Currencies

International

Treasuries

Amarin Corporation plc - American Depositary Shares (NQ:AMRN)

14.54 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Mar 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amarin Corporation plc - American Depositary Shares

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Amarin Corp: Q3 Earnings Insights ↗

October 27, 2022

Amarin Corp (NASDAQ:AMRN) reported its Q3 earnings results on Thursday, October 27, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Amarin Reports Third Quarter 2022 Financial Results and Provides Business Update

October 27, 2022

From Amarin Corporation plc

Via GlobeNewswire

Earnings Preview For Amarin Corp ↗

October 26, 2022

Amarin Corp (NASDAQ:AMRN) is set to give its latest quarterly earnings report on Thursday, 2022-10-27. Here's what investors need to know before the announcement. Analysts estimate that Amarin Corp...

Via Benzinga

Amarin Appoints Adam Berger and Geraldine Murphy to Board of Directors

October 20, 2022

From Amarin Corporation plc

Via GlobeNewswire

Amarin to Report Third Quarter 2022 Financial Results And Host Conference Call on October 27, 2022

October 20, 2022

From Amarin Corporation plc

Via GlobeNewswire

Amarin Touts Positive Data For Its Heart Disease Drug In Current/Former Smokers ↗

August 29, 2022

Via Benzinga

Amarin Corp Earnings Perspective: Return On Capital Employed ↗

August 08, 2022

Via Benzinga

Amarin Board of Directors Issues Statement in Response to Sarissa

October 11, 2022

From Amarin Corporation plc

Via GlobeNewswire

Sarissa Capital Has Commenced the Process to Call a Special Meeting of Amarin Shareholders to Remove and Replace Certain Board Members

October 11, 2022

From Sarissa Capital Management LP

Via Business Wire

3 Biotech Stocks Gaining Momentum

September 12, 2022

The headlines have been particularly good for a trio of small cap biotechs and it appears the momentum may have staying power.

Via MarketBeat

MarketBeat: Week in Review 8/22 - 8/26

August 27, 2022

The markets are selling on news that interest rate hikes will continue past September. But here are some of the other stories for investors to follow this week

Via MarketBeat

Topics Economy

Amarin Still Suspends FY22 Guidance On Generic Challenges ↗

August 03, 2022

Via Benzinga

Amarin Corp: Q2 Earnings Insights ↗

August 03, 2022

Amarin Corp (NASDAQ:AMRN) reported its Q2 earnings results on Wednesday, August 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Amarin Outlines $100M Cost Saving Plan ↗

June 06, 2022

Via Benzinga

Amarin's New Vascepa Data Shows Significant Reduction In Heart Attack Subtypes ↗

August 26, 2022

New data shows that Amarin Corporation plc's (NASDAQ: AMRN) Vascepa/Vazkepa (icosapent ethyl) significantly reduced ST-segment and non-ST elevation myocardial infarction (NSTEMI) and other MI subtypes...

Via Benzinga

7 F-Rated Growth Stocks to Sell Before Q4 ↗

August 25, 2022

Challenging market conditions make these growth stocks to sell a detriment to your portfolio if you don't dump them before Q4.

Via InvestorPlace

Are Ocugen or Amarin Good Penny Stocks to Buy?

August 24, 2022

This article discusses the current state of Ocugen and Amarin, two penny stocks that highlight the risk and (potential) reward of penny stock investing.

Via MarketBeat

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 22, 2022

Via Benzinga

Why MSP Recovery Is Trading Higher By Over 21%, Here Are 61 Stocks Moving In Monday's Mid-Day Session ↗

August 22, 2022

Losers

Via Benzinga

Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday ↗

August 23, 2022

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of...

Via Benzinga

AMC Entertainment, Pharvaris And Some Other Big Stocks Moving Lower On Monday ↗

August 22, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 19, 2022

Gainers

Via Benzinga

Does Amarin Deserve a Spot in Your Portfolio after Earnings ?

August 04, 2022

Amarin recently announced its earnings for Q2'22 with mixed results. Here we'll examine the pros and cons of having this penny stock in your portfolio.

Via MarketBeat

Topics Earnings

Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial ↗

August 03, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

This Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving Premarket ↗

August 03, 2022

Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares rose 159.3% to $1.67 in pre-market trading after dropping 13% on Tuesday.

Via Benzinga

Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session ↗

July 01, 2022

Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 56.1% to $ 0.7029 after dropping 10% on Thursday.

Via Benzinga

Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday ↗

July 01, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase...

Via Benzinga

Sarissa Capital Intends to Vote “Abstain” at the Amarin Annual Meeting

June 15, 2022

From Sarissa Capital Management LP

Via Business Wire

Looking Into Amarin Corp's Return On Capital Employed ↗

May 16, 2022

Amarin Corp (NASDAQ:AMRN) brought in sales totaling $94.63 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 314.74%, resulting in a loss of $31.56 million.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022 ↗

May 06, 2022

Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading...

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.